Jan 29, 2026
List pharmaceutical companies which allow independent reanalysis of participant‑level data
A substantial subset of large pharmaceutical firms have formal policies or platforms that permit of de‑identified participant‑level data (PLD), but access is heterogeneous, conditional, and often medi...